Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Proteome Sciences Shares Surge: Why Is PRM Stock Jumping Over 26%?

• PRM shares surged 26.47% on 13 July 2026, closing at 2.15 GBX.• Proteome Sciences PLC has a market capitalization of approximately 5.96 million GBP, placing it in the micro-cap segment.• The company provides proteomics services and biomarker discovery solutions for pharmaceutical, biotechnology, and …

Ankur Sharma | 13 July 2026

AstraZeneca's Next Growth Gamble: Can Science, China and the US Power a New Era for the Pharma Giant?

AstraZeneca, one of Britain's most valuable listed companies, is pursuing an 80 billion US dollar revenue ambition for 2030 built on scientific risk-taking, heavy US investment and a large China business. A failed Wainua heart-drug trial on 9 July 2026 knocked its London shares …

Ankur Sharma | 13 July 2026

Is LSE:FAB Still One of the UK's Most Promising Small-Cap Healthcare Stocks to Watch?

LSE:FAB came under selling pressure during the latest trading session, with shares finishing4.35% lower.

Ankur Sharma | 13 July 2026

Best UK Healthcare Stocks to Watch as Pharma Innovation, AI and Biotechnology Drive Growth

The UK Healthcare sector remains one of the most closely followed industries on the London Stock Exchange during July 2026 as pharmaceutical innovation, biotechnology breakthroughs and artificial intelligence continue reshaping global healthcare. Investors continue favouring healthcare companies because they combine defensive characteristics with long-term …

Ankur Sharma | 11 July 2026

Can Proteome Sciences Benefit from the Rapid Growth of Biomarker Research and Precision Medicine?

Proteome Sciences plc has returned to investor watchlists as growing interest in precision medicine, personalised healthcare and advanced diagnostics continues reshaping the global biotechnology industry.

Ankur Sharma | 10 July 2026

GENinCode PLC: Why Is LSE:GENI Back on Investors' Watchlists? UK Genetic Testing Stock Gains Fresh Attention Amid Precision Medicine Growth

GENinCode PLC has once again become one of the healthcare companies attracting attention across the London market as investors continue evaluating businesses positioned within one of healthcare's fastest-growing segments—precision medicine.

Ankur Sharma | 10 July 2026

Can Futura Medical Scale Its DermaSys Technology Into Global Commercial Success?

Investors continue to monitor commercial sales performance in markets where the company's gel treatment has already launched, given the importance of demonstrating sustained consumer demand.

Divya Sood | 10 July 2026

Oxford Nanopore Shares Edge Higher: Why Are Investors Watching ONT Stock?

• ONT shares gained 1.26% on 10 July 2026, closing at 120.40 GBX.• Oxford Nanopore Technologies PLC has a market capitalization of approximately 1,159.57 million GBP, placing it in the mid-cap segment.• The company develops nanopore sequencing technology for genomics, clinical research, and life …

Ankur Sharma | 10 July 2026

EDX Medical Group Shares Surge: What's Fueling Investor Interest in EDX Stock?

• EDX shares gained 7.69% on 10 July 2026, closing at 10.50 GBX.• EDX Medical Group PLC has a market capitalization of approximately 40.17 million GBP, placing it in the small-cap segment.• The company develops diagnostic testing services and precision medicine solutions for healthcare …

Ankur Sharma | 10 July 2026

MedPal AI Shares Ease Slightly: Why Are Investors Watching MPAL Stock?

• MPAL shares declined 0.41% on 10 July 2026, closing at 3.39 GBX.• MedPal AI PLC has a market capitalization of approximately 26.17 million GBP, placing it in the micro-cap segment.• The company focuses on artificial intelligence-powered healthcare and digital health solutions.• Product development, …

Ankur Sharma | 10 July 2026
Support

Hi! How can we help you today?

Loading…